Plant protogenesis powder for treating squamous-cell carcinoma and cancer pain

Abstract

The invention discloses a plant protogenesis powder for treating squamous-cell carcinoma and cancer pain. Through hard working for many years, an inventor finds and verifies that masson pine protogenesis powder can lock and selectively treat the cancer pain for the first time; the effective rate of the squamous-cell carcinoma by old masson pine bark is up to 99.9-99.99% and even 100%; the inhibition rate of cancer pain is up to 88.5-99%, thus the cancer pain can be effectively reduced. The possible acting mechanism is that the cancer pain resistance is displayed through inhibiting cell proliferation, inducing cell apoptosis and inhibiting angiogenesis. The plant protogenesis powder has strong target to treat squamous-cell carcinoma and cancer pain, does not generate drug resistance and isfree from intersection with traditional chemotherapeutic drugs. The old masson pine bark protogenesis powder is expected to be a new plant drug for treating squamous-cell carcinoma and cancer pain.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a raw plant powder and its application, in particular to the old bark powder of Pinus massoniana and its application. Background technique [0002] The threat of cancer to human beings is increasing day by day, and it has become the "number one killer" that endangers human health and life. Conquering cancer has become an urgent task facing all mankind, and all countries have invested huge sums of money in researching it as an important subject. At present, due to the limitations of surgical treatment and radiotherapy and chemical treatment, as well as the emergence of toxic and side effects of chemicals, the international scientific community has begun to turn its attention to more natural plant extracts for cancer treatment, which has become a research hotspot for scientists. [0003] A large number of experiments have proved that surgery can only remove visible cancerous tissue, but it...

AI Technical Summary

Problems solved by technology

Including spindle cell carcinoma, which is the most common type, accounting for about 40%-50% of primary lung cancer. More than 1.90% of lung squamous cell, the treatment of lung squamous cell carcinoma is said to say that the first cycle of chemotherapy for lung squamous cell carcinoma The effect of sensitive treatment can reach 25%, the effect of chemotherapy in the second cycle can reach 15%, the effect of the third cycle can reach 5%, and the effect after three cycles is basically zero. It is complicated. Although distant metastasis of lung squamous cell carcinoma occurs later, distant metastasis such as liver metastasis is also an inherent attribute of lung squamous cell carcinoma. Liver metastasis is also a common metastasis site of lung squamous cell carcinoma, and brain metastasis is a common metastasis site of lung squamous cell carcinoma. Generally speaking, patients with brain metastases are more dangerous and difficult to treat. How to control the spread of the disease is the best treatment.

Images